Alliance Life Sciences Examines the Need for Gross-to-Net Professional Expertise Paired with Technology to Create a Competitive Advantage

By Posted in - Client News on February 2nd, 2016 0 Comments

AllianceLogo2013

Media Contact:
CPR for Alliance Life Sciences
Joelle Caputa; jcaputa@cpronline.com
201.641.1911 x54

Alliance Life Sciences Examines the Need for Gross-to-Net Professional Expertise Paired with Technology to Create a Competitive Advantage 

Download “Robust Gross-to-Net Analytics Empower Pharmcos to Unlock Growth Potential

SOMERSET, N.J. / LONDON – February 2, 2016 — Alliance Life Sciences, a leading global life sciences consultancy and technology provider, furthers its industry leadership with the release of its white paper, “Robust Gross-to-Net Analytics Empower Pharmcos to Unlock Growth Potential.” Authored by Deborah Chase, associate director, Contracting & Pricing Solutions, and Charlene Washer, managing consultant, Alliance Life Sciences, the paper illustrates how an in-depth understanding of gross-to-net (GTN) data transforms an accounting function into a strategic management tool.

“No single solution on the market today can address the multiplicity of variables that drive gross-to-net calculations, requiring companies to engineer robust processes to unlock growth potential,” commented James Burke, chief strategy officer, Alliance Life Sciences. “The best first step for an organization is to make a detailed assessment to diagnose the issues and choose the best solution partner to address identified needs.”

Burke adds that improving GTN management as a means to drive profits must go beyond simply meeting requirements. A deep understanding of revenue and demand drivers, and how discounts and liabilities affect these factors, is essential. Greater accuracy in the accruals process leads to fewer adjustments, and greater predictability in cash flow.

With the goal to improve methodologies and forecast financial exposure for reserves with greater accuracy, experts can help pharmcos to make decisions concerning processes and system configuration that will go beyond these operational concerns, and generate data analytics that enable more efficient discounting and create a competitive advantage.

To learn more about the value of assessments to improve efficiency, download “Robust Gross-to-Net Analytics Empower Pharmcos to Unlock Growth Potential.”

About Alliance Life Sciences   

Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. With over ten years of dedicated life sciences experience, our worldwide team of experts provides insights into contracting, pricing, and access. We serve mid-market life sciences companies and eight of the top-10 pharmaceutical manufacturers. Contact: 866-581-4850 or www.alscg.com.

Comments are closed.